View Older Stories View More Recent Stories

Jun 4, 2024 11:16AM Lev expands suite of CRE services with launch of AI-powered pipeline management tool
May 15, 2024 04:20PM Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 14, 2024 09:00AM Truveris Secures $15 Million in Series E Funding Through Canaan Partners and New Leaf Venture Partners
Apr 24, 2024 04:05PM Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Apr 18, 2024 07:00AM Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic
Apr 5, 2024 04:30PM Form 13F-HR Canaan Partners XI LLC For: Mar 31
Apr 5, 2024 04:30PM Form 13F-HR Canaan Partners IX LLC For: Mar 31
Apr 3, 2024 07:51AM Cancer biotech firm Alterome Therapeutics raises $132 million in Goldman Sachs-led round
Apr 3, 2024 06:00AM Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives
Mar 26, 2024 02:50PM Software Supply Chain Security Leader Binarly Closes $10.5 Million Financing Led by Two Bear Capital
Mar 14, 2024 09:00AM Lily AI Closes $20M Series B-1 Funding Round
Mar 4, 2024 08:00AM Nocion Therapeutics Announces $62 Million Series B Financing to Advance Lead Program in Cough into Later Stage Development
Feb 14, 2024 08:00AM IPSecure Closes Multiple Seven-Figure Seed II Round of Funding and Announces Formation of Key Advisory Board
Feb 1, 2024 04:31PM Form 13F-HR Canaan Partners IX LLC For: Dec 31
Feb 1, 2024 04:31PM Form 13F-HR Canaan Partners XI LLC For: Dec 31
Jan 23, 2024 09:00AM Dusty Robotics Unveils Second Generation Robot and Comprehensive BIM-to-Field Automated Workflow
Nov 29, 2023 02:00PM Reibus International Announces CEO Transition
Nov 15, 2023 10:00AM Fireflies.ai Launches Mobile App, Bringing Its AI Notetaker to In-Person Meetings
Oct 17, 2023 11:00AM JOOR Raises $25M to Accelerate Growth and Innovation; Expand in Payments and New Categories
Oct 11, 2023 04:30PM Form 13F-HR Canaan Partners X LLC For: Sep 30
Oct 11, 2023 04:30PM Form 13F-HR Canaan Partners XI LLC For: Sep 30
Oct 2, 2023 08:00AM Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors
Sep 27, 2023 07:00AM Pathios Therapeutics Awarded Innovate UK Grant to Evaluate First-in-Class Immunotherapy Approach in Models of Malignant Brain Cancer
Sep 26, 2023 02:00AM Acesion Pharma Closes Oversubscribed €45M Series B Financing Round to Advance Development of Novel Therapy for Atrial Fibrillation
Sep 19, 2023 09:30AM Lev Announces the Launch of Lev AI
Sep 13, 2023 07:00AM ThirtyFiveBio Awarded Innovate UK Biomedical Catalyst Grant to Advance GPR35 Inhibitor Program for Treatment of Gastrointestinal Disease and Cancers
Aug 10, 2023 04:44PM Atmosfy Announces $12 Million in Seed Funding as it Surpasses One Million Local Businesses on the Platform
Jul 13, 2023 04:30PM Form 13F-HR Canaan Partners X LLC For: Jun 30
Jul 13, 2023 04:30PM Form 13F-HR Canaan Partners XI LLC For: Jun 30
Jun 20, 2023 09:00AM World View Names New Chief Financial Officer and Appoints New Member to Its Board of Directors
Jun 2, 2023 10:00AM CircleUp Acquired by Brightflow AI
Jun 1, 2023 05:50PM Brightflow AI Acquires CircleUp to Deepen Customer Insights and Help Small Businesses Grow
May 18, 2023 08:00AM OncoResponse Awarded $13 Million in Funding from CPRIT and Raises $14 Million in Added Funds from Investors to Advance Cancer Immunotherapy
May 10, 2023 09:30AM Lev Announces the Launch of Lev Match
Apr 27, 2023 07:00AM Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital and Names Kristine Ball President and CEO
Apr 19, 2023 09:00AM Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain
Apr 19, 2023 09:00AM Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain
Apr 19, 2023 09:00AM OncoResponse Presents at AACR 2023 Annual Meeting Preclinical Data Highlighting Dual Antagonist Antibodies Targeting both LILRB1 and LILRB2
Apr 17, 2023 07:00AM Pathios Therapeutics Unveils PTT-4256, a Highly Potent and Selective Inhibitor of GPR65, in Presentation at American Association for Cancer Research (AACR) Annual Meeting 2023
Apr 16, 2023 03:30PM Researchers Report Clinical Proof-of-Concept Data for Vivace Therapeutics' VT3989, a First for a Cancer Drug Targeting the Hippo Pathway, in Oral Presentation at AACR 2023
Apr 6, 2023 04:31PM Form 13F-HR Canaan Partners XI LLC For: Mar 31
Apr 6, 2023 04:30PM Form 13F-HR Canaan Partners X LLC For: Mar 31
Mar 30, 2023 07:00AM ThirtyFiveBio Emerges From Stealth with Presentation of First Data from GPR35 Antagonist Program at American Association for Cancer Research (AACR) Annual Meeting 2023
Mar 15, 2023 02:05PM OncoResponse Announces Presentation of Preclinical Data on Dual Antibodies Targeting LILRB1 and LILRB2 at American Association for Cancer Research Annual Meeting 2023 (AACR 2023)
Mar 15, 2023 07:30AM Vivace Therapeutics to Unveil First Clinical Data for a Cancer Drug Targeting the Hippo Pathway
Feb 14, 2023 07:00AM Halda Therapeutics unveils its first pipeline data for RIPTAC™ therapeutics, a new drug modality, at ASCO GU Symposium
Feb 1, 2023 04:32PM Form 13F-HR Canaan Partners X LLC For: Dec 31
Feb 1, 2023 04:31PM Form 13F-HR Canaan Partners XI LLC For: Dec 31
Feb 1, 2023 04:31PM Form 13F-HR Canaan Partners IX LLC For: Sep 30
Jan 31, 2023 03:08PM Appsmith Launches Partner Program to Empower Businesses to Build Business Critical Applications
View More Recent Stories View Older Stories